Advertisement
Canada markets open in 4 hours 45 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7332
    +0.0009 (+0.12%)
     
  • CRUDE OIL

    83.80
    +0.23 (+0.28%)
     
  • Bitcoin CAD

    87,848.08
    +729.21 (+0.84%)
     
  • CMC Crypto 200

    1,389.08
    -7.46 (-0.53%)
     
  • GOLD FUTURES

    2,359.30
    +16.80 (+0.72%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,748.25
    +180.75 (+1.03%)
     
  • VOLATILITY

    15.52
    +0.15 (+0.98%)
     
  • FTSE

    8,107.23
    +28.37 (+0.35%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6818
    -0.0003 (-0.04%)
     

Why ConMed Is Expected to Report Robust Revenue Growth in 2018

Why ConMed Is Expected to Report Robust Revenue Growth in 2018

ConMed (CNMD) expects to report revenue growth in the range of 5%–6.5% on a reported basis and in the range of 4.0%–5.0% on a CC (constant currency) basis for fiscal 2018. The company has projected a favorable top-line impact of 100–150 basis points, resulting from foreign exchange movements for fiscal 2018. In 2017, ConMed reported a ~4.3% YoY (year-over-year) rise in revenues on a CC basis, which would be in line with the average revenue growth in the medical technology industry.